Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

Gut microbiota dysbiosis has been repeatedly observed in obesity and type 2 diabetes
mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease …

Background and aims Metabolic associated fatty liver disease (MAFLD) is a novel concept
proposed in 2020, the utility of which has not been tested and validated in real world. We …

Non-alcoholic fatty liver disease (NAFLD) is one the fastest emerging manifestations of the
metabolic syndrome worldwide. Non-alcoholic steatohepatitis (NASH), the progressive form …

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …

Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver
disease worldwide. Asia is a large, heterogeneous area with substantial variation in …

In medicine, language matters and the words used to name and describe a disease can
have a profound impact on patients and their families. Over the last two decades, many …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver
disease (ALD) cannot reliably be distinguished by routine diagnostics, and the role of …

Exercise and diet are treatments for nonalcoholic fatty liver disease (NAFLD) and
prediabetes, however, how exercise and diet interventions impact gut microbiota in patients …